GHK-Cu / KPV
SKU：ghk-cu-kpv
Price：USD 85.00
Product information
This 70 mg blend contains 50 mg GHK-Cu and 20 mg KPV. Its ingredients have different research backgrounds: matrix-related endpoints for the copper-binding tripeptide and NF-kB-associated inflammatory signalling for KPV. The combined formulation has not been characterized as a single entity. Separate component literature does not establish the effectiveness or clinical activity of the complete blend.
Product specifications
- Components
- GHK-Cu + KPV
- Content
- 70 mg per vial (50 mg GHK-Cu + 20 mg KPV)
- GHK-Cu Sequence
- Gly-His-Lys (copper complex)
- KPV Sequence
- Lys-Pro-Val (α-MSH 11-13)
- KPV Molecular Weight
- 342.43 g/mol
- Form
- Lyophilized powder blend
- Purity
- ≥99% by HPLC
- Solubility
- Water-soluble
- Storage
- -20°C, protected from light
- Classification
- Research use only
- Label amount
- 50mg / 20mg
Analysis report
No test report for the selected option
Match the product, option and lot in the report.
Research information
Read the full GHK-Cu / KPV research monograph
Research overview
This 70 mg blend contains 50 mg GHK-Cu and 20 mg KPV. Its ingredients have different research backgrounds: matrix-related endpoints for the copper-binding tripeptide and NF-kB-associated inflammatory signalling for KPV. The combined formulation has not been characterized as a single entity. Separate component literature does not establish the effectiveness or clinical activity of the complete blend.